2. Anti-infection
  3. Bacterial Antibiotic
  4. Orbifloxacin

Orbifloxacin is an orally administrable Antibiotic. Orbifloxacin disrupts the replication and proliferation of Bacterial DNA, inhibits bacterial growth and exerts bactericidal activity. Orbifloxacin inhibits the growth of canine-derived E. coli and Pseudomonas aeruginosa isolates. Orbifloxacin is used in research related to bacterial infections.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Orbifloxacin

Orbifloxacin Chemische Struktur

CAS. Nr. : 113617-63-3

Größe Preis Verfügbarkeit Menge
Kostenlose Probe (0.1 - 0.2 mg)   Jetzt bewerben  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 Auf Lager
Solution
10 mM * 1 mL in DMSO Auf Lager
Solid
50 mg Auf Lager
100 mg Auf Lager
200 mg Auf Lager
500 mg   Angebot einholen  
1 g   Angebot einholen  

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Kundenbewertung

Based on 1 publication(s) in Google Scholar

Other Forms of Orbifloxacin:

Orbifloxacin Related Antibodies

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Orbifloxacin

Alle Antibiotic Isoform-spezifische Produkte anzeigen:

Alle Isoformen anzeigen
Aminoglycoside Glycopeptide Lipopeptide Macrolide Oxazolidinone Quinolone Tetracycline β-lactam

  • Biologische Aktivität

  • Reinheit & Dokumentation

  • Verweise

  • Kundenbewertung

Beschreibung

Orbifloxacin is an orally administrable Antibiotic. Orbifloxacin disrupts the replication and proliferation of Bacterial DNA, inhibits bacterial growth and exerts bactericidal activity. Orbifloxacin inhibits the growth of canine-derived E. coli and Pseudomonas aeruginosa isolates. Orbifloxacin is used in research related to bacterial infections[1][2][3][4].

IC50 & Target

Quinolone

 

In Vitro

Orbifloxacin (0.015-4.0 μg/mL; up to 7 days) inhibits the growth of Piscirickettsia salmonis LF-89 VR-1361, and its growth-inhibitory effect persists throughout the 7-day incubation period compared with the untreated control group[1].
Orbifloxacin (0.1×-4× MIC; 0-24 h) inhibits the growth of Staphylococcus aureus ATCC 29213 and ATCC 43300, with MIC values of 0.5 mg/L and 4 mg/L, respectively, and induces concentration-dependent post-antibiotic effect (PAE) and post-antibiotic sub-MIC effect (PA-SME)[2].
Orbifloxacin (at twice the MIC; 1 h) induces a post-antibiotic effect (PAE) with an average duration of 0.29 h in clinical canine isolates of E coli, and an average PAE duration of 0.37 h in clinical canine isolates of Pseudomonas aeruginosa[3].
Orbifloxacin (0.1×MIC-0.3×MIC) induces concentration-dependent PA-SMEs in canine clinical isolates of E coli (mean 0.55 to 2.03 h) and Pseudomonas aeruginosa (mean 1.04 to 2.47 h)[3].
Orbifloxacin (0.016-16 mg/L; 18 h) inhibits visible growth of clinical Staphylococcus intermedius strains isolated from canine skin and ear infections by 50% and 90% at concentrations of 0.5 mg/L and 1 mg/L, respectively[4].
Orbifloxacin (0.063-4 mg/L; 1-24 h) exhibits concentration-dependent bactericidal activity against Staphylococcus aureus ATCC 29213, and time-dependent bactericidal activity against Staphylococcus intermedius isolates from pyoderma[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Orbifloxacin Related Antibodies
Parmacokinetics
Species Dose Route T1/2 Tmax Cmax AUC0-last AUC0-∞ Vd/F CL/F MRT0-last F Vd CL
Mice[2] 2.5 mg/kg i.v. 1.09 h 0.08 h 1.96 mg/L 1.72 μg·h/mL 1.74 μg·h/mL / / 1 h / 2.28 L/kg 1.47 L/h/kg
Mice[2] 5 mg/kg i.v. 1.12 h 0.08 h 3.78 mg/L 4.78 μg·h/mL 4.86 μg·h/mL / / 1.29 h / 1.67 L/kg 1.04 L/h/kg
Mice[2] 20 mg/kg i.v. 2.08 h 0.08 h 8.84 mg/L 17.06 μg·h/mL 17.09 μg·h/mL / / 1.84 h / 3.64 L/kg 1.20 L/h/kg
Mice[2] 80 mg/kg i.v. 1.95 h 0.19 h 21.8 mg/L 54.94 μg·h/mL 54.98 μg·h/mL / / 3.17 h / 4.18 L/kg 1.48 L/h/kg
Mice[2] 2.5 mg/kg i.m. 1.36 h 0.25 h 1.45 mg/L 1.73 μg·h/mL 1.77 μg·h/mL 2.96 L/kg 1.47 L/h/kg 1.14 h 99.9 % / /
Mice[2] 5 mg/kg i.m. 1.42 h 0.22 h 4.18 mg/L 5.12 μg·h/mL 5.15 μg·h/mL 2.00 L/kg 0.98 L/h/kg 1.31 h 107.5 % / /
Mice[2] 20 mg/kg i.m. 2.24 h 0.25 h 9.03 mg/L 18.80 μg·h/mL 18.85 μg·h/mL 3.60 L/kg 1.14 L/h/kg 1.94 h 109.2 % / /
Mice[2] 80 mg/kg i.m. 2.02 h 0.25 h 27.13 mg/L 53.94 μg·h/mL 53.98 μg·h/mL 4.43 L/kg 1.52 1.74 h 98.2 % / /
In Vivo

Orbifloxacin (2.5-80 mg/kg; i.m.; twice daily; 24 hours) has an AUC24h/MIC ratio (R2 > 0.98) that is a strong predictor of its in vivo antibacterial efficacy against S. aureus, with targets of 33.78-37.79 h for bacteriostatic activity and 179.43-217.47 h for 3-log10 bacterial kill[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c (specific-pathogen-free, 6 weeks old, both sexes, 18 to 20 g, neutropenic thigh infection model induced via intraperitoneal cyclophosphamide)[2]
Dosage: 2.5 mg/kg ; 5 mg/kg ); 20 mg/kg; 80 mg/kg
Administration: i.m.; twice daily; 24 hours
Result: Partially inhibited bacterial growth over 24 hours at total daily doses of 5 and 10 mg/kg.
Inhibited bacterial replication at a total daily dose of 40 mg/kg.
Reduced the bacterial load in the thigh by a maximum of 3.12 log10 over 24 hours at a maximum total daily dose of 160 mg/kg.
Molekulargewicht

395.38

Formel

C19H20F3N3O3
CAS. Nr.
Appearance

Solid

Color

White to off-white

SMILES

O=C(C1=CN(C2CC2)C3=C(C(F)=C(F)C(N4C[C@H](C)N[C@H](C)C4)=C3F)C1=O)O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
Lösungsmittel & Löslichkeit
In Vitro: 

DMSO : 6 mg/mL (15.18 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.5292 mL 12.6461 mL 25.2921 mL
5 mM 0.5058 mL 2.5292 mL 5.0584 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

  • Molaritätsrechner

  • Verdünnungsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Reinheit & Dokumentation
Verweise

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.5292 mL 12.6461 mL 25.2921 mL 63.2303 mL
5 mM 0.5058 mL 2.5292 mL 5.0584 mL 12.6461 mL
10 mM 0.2529 mL 1.2646 mL 2.5292 mL 6.3230 mL
15 mM 0.1686 mL 0.8431 mL 1.6861 mL 4.2154 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Orbifloxacin Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Orbifloxacin113617-63-3CP-104354CP104354CP 104354BacterialAntibioticPiscirickettsia salmonisStaphylococcus aureusE coliStaphylococcus intermediusbacterial infections
Inhibitorinhibitorinhibit

Ihre kürzlich angesehenen Produkte:

Online-Anfrage

Your information is safe with us. * Required Fields.

Produktname

  

Requested Quantity *

Name des Antragstellers *

 

Anrede

E-Mail-Addresse *

 

Telefonnummer *

Department

 

Name der Organisation *

City

Bundesland

Country or Region *

      

Bemerkungen

Massenanfrage

Inquiry Information

Produktname:
Orbifloxacin
Art. -Nr.:
HY-B0915
Menge:
MCE Japan Authorized Agent:

Kundenbewertung

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Produktname

  

Lot #

Name des Antragstellers *

 

E-Mail-Addresse *

Telefonnummer

 

Department *

Name der Organisation *

 

Country or Region *

Bemerkungen

SAFETY DATA SHEET (SDS)

English - EN (252 KB) Français - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Español - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.